menu search

Preclinical data demonstrate anti-siglec-15 treatment reduced bone loss and enhanced bone quality in mice with moderate-to-severe osteogenesis imperfecta (oi)

Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting BELTSVILLE, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) — N...

October 17, 2023, 12:05 pm

Abbvie: why you should pay attention to this high-yielding dividend king (rating downgrade)

Dividend Kings are the most battle-tested dividend payers on Wall Street, with AbbVie being just one of four in the healthcare sector. The pharmaceuti...

October 17, 2023, 9:20 am

Dr. christopher fox and n.p. sarah sato collaborate with castle connolly private health partners to create the alpine center ccphp concierge medicine program

The Alpine Center CCPHP—for patients who desire a more personalized approach to healthcare care SUPERIOR, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) — ...

October 16, 2023, 3:00 pm

Intellia's (ntla) hae candidate gets ema's prime designation

The European Medicines Agency bestows a Priority Medicines (PRIME) designation to Intellia's (NTLA) in vivo CRISPR-based investigational therapy, NTLA...

October 16, 2023, 2:17 pm

Snack maker mondelez int'l is down but not out

In an unprecedented battle between modern medicine and traditional snacks, Mondelez International, Inc....

October 16, 2023, 12:21 pm

Comera life sciences presents sqore™ platform technology data at podd: partnerships in drug delivery conference

WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generat...

October 16, 2023, 12:00 pm

Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc

Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of NSCLC CAMBRIDG...

October 16, 2023, 11:00 am

Gsk cancer immunotherapy receives backing from key ema committee

GSK PLC (LSE:GSK, NYSE:GSK) said its cancer immunotherapy drug, Jemperli (dostarlimab), has been recommended for approval by a key committee at the E...

October 16, 2023, 4:02 am

Merck to present latest research from oncology portfolio at esmo 2023

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research ...

October 16, 2023, 2:00 am

Precede biosciences announces first scientific data from its liquid biopsy platform to be presented as an oral presentation at esmo 2023

Data from more than 400 patients across 15 cancers demonstrate the significance of the Precede approach to informing therapeutic decision making and c...

October 15, 2023, 10:05 pm

Gene therapy, parkinson's disease, and food science: bayer u.s. discusses the latest technology

Most Americans know Bayer (BAYN.DE) for its over-the-counter medicines like Aleve and Claritin. But that's not all the company does....

October 15, 2023, 9:00 am

Mineralys therapeutics announces upcoming poster presentations at two scientific conferences in november 2023

Late-breaking poster presentation at ASN’s Kidney Week 2023 – – –Poster presentation at AHA’s Scientific Sessions 2023 RADNOR, Pa., Oct. 13,...

October 13, 2023, 8:10 pm

Mind medicine: q4 of 2023 data for gad makes this worth a look

Results from the phase 2b study, using MM-120 for the treatment of patients with generalized anxiety disorder, expected Q4 of 2023. The Generalized An...

October 13, 2023, 6:37 pm

Revolution medicines presents encouraging clinical data for rmc-6236 and rmc-6291 at 2023 triple meeting

Clinical dose escalation data for RMC-6236, a RASMULTI(ON) Inhibitor, show oral bioavailability, well-tolerated safety profile and preliminary evidenc...

October 13, 2023, 3:50 pm

Why shares of revolution medicines were popping on friday

Revolution Medicines is a clinical-stage biotech. The company has nearly a million in cash to develop its deep pipeline....

October 13, 2023, 2:54 pm

Cidara therapeutics and mundipharma receive positive chmp opinion for rezafungin for the treatment of invasive candidiasis in adults(1)

The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and e...

October 13, 2023, 2:34 pm

Mangoceuticals announces tv air dates for interview featuring ceo jacob cohen on bloomberg tv and fox business

Dallas, Texas, Oct. 13, 2023 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on develo...

October 13, 2023, 1:40 pm

Intellia therapeutics receives priority medicines (prime) designation from the european medicines agency for ntla-2002, an investigational in vivo crispr genome editing treatment for hereditary angioe

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focuse...

October 13, 2023, 12:38 pm

Intellia therapeutics receives priority medicines (prime) designation from the european medicines agency for ntla-2002, an investigational in vivo crispr genome editing treatment for hereditary angioe

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focuse...

October 13, 2023, 12:38 pm

: amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator

Amylyx Pharmaceuticals Inc. AMLX shares fell 7.5% premarket on Friday after the company said the European Medicines Agency had confirmed its negative ...

October 13, 2023, 12:31 pm


Search within

Pages Search Results: